Gefitinib and erlotinib are commonly used as salvage treatment of unselected patients with recurrent NSCLC after first-line chemotherapy. This practice is primarily based on the results from the ...
Notable examples include imatinib for treating chronic myelogenous leukemia and gastrointestinal tumors, gefitinib and erlotinib for non-small-cell lung cancers, trastuzumab in women with breast ...